Gene Therapy - Table of Contents alert Volume 23 Issue 11

If you are unable to see the message below, click here to view.

Advertisement Looking for cGMP AAV and Lentivirus Production?  Proven cGMP facility, team and quality system for CAR-T and gene therapy Read more for cGMP floor plan and QC tests. TABLE OF CONTENTS Volume 23, Issue 11 (November 2016) In this issue Original Articles Short Communications Corrigendum Erratum Also new AOP Advertisement nature.com webcasts Join us for our upcoming webcast with live Q&A:  ADVANCES IN PRECISION MEDICINE AND GENOMIC SEQUENCING Presented by BioPharma Dealmakers Date: Tuesday, November 29 2016 Time: 8AM PST, 11AM EST, 4PM GMT, 5PM CET  REGISTER FOR FREE Sponsored by: Aperiomics Inc. | Bluebee | iNanoBio | Becton Dickinson (BD) Sign up for e-alerts Recommend to your library Web feed Subscribe Advertisement Take a look at our new Editor's Choice page Gene Therapy is delighted to share with you an Editor's Choice selection of key papers that highlight some of the best current research published in the journal. These papers showcase the breadth of scope and coverage that this journal consistently delivers to its readers, and have been selected because readers will find them particularly interesting or useful. View the Editor's Choice articles   Original Articles Top Single residue AAV capsid mutation improves transduction of photoreceptors in the Abca4−/− mouse and bipolar cells in the rd1 mouse and human retina ex vivo S R De Silva, P Charbel Issa, M S Singh, D M Lipinski, A O Barnea-Cramer, N J Walker, A R Barnard, M W Hankins and R E MacLaren Gene Ther 2016 23: 767-774; advance online publication, July 14, 2016; 10.1038/gt.2016.54 Abstract | Full Text Construction and validation of an RNA trans-splicing molecule suitable to repair a large number of COL7A1 mutations OPEN B Tockner, T Kocher, S Hainzl, J Reichelt, J W Bauer, U Koller and E M Murauer Gene Ther 2016 23: 775-784; advance online publication, August 11, 2016; 10.1038/gt.2016.57 Abstract | Full Text Electroporation-mediated delivery of the FER gene in the resolution of trauma-related fatal pneumonia V A Dolgachev, R Goldberg, M V Suresh, B Thomas, N Talarico, M R Hemmila, K Raghavendran and D Machado-Aranda Gene Ther 2016 23: 785-796; advance online publication, July 22, 2016; 10.1038/gt.2016.58 Abstract | Full Text Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction D Vavrincova-Yaghi, L E Deelman, H van Goor, M A Seelen, P Vavrinec, I P Kema, P Gomolcak, A Benigni, R H Henning and M Sandovici Gene Ther 2016 23: 797-806; advance online publication, July 25, 2016; 10.1038/gt.2016.59 Abstract | Full Text Short Communications Top Characterization of a novel adeno-associated viral vector with preferential oligodendrocyte tropism S K Powell, N Khan, C L Parker, R J Samulski, G Matsushima, S J Gray and T J McCown Gene Ther 2016 23: 807-814; advance online publication, September 15, 2016; 10.1038/gt.2016.62 Abstract | Full Text The long terminal repeat negative control region is a critical element for insertional oncogenesis after gene transfer into hematopoietic progenitors with Moloney murine leukemia viral vectors Y Ikawa, T Uchiyama, G J Jagadeesh and F Candotti Gene Ther 2016 23: 815-818; advance online publication, August 4, 2016; 10.1038/gt.2016.51 Abstract | Full Text Corrigendum Top Exosome-associated AAV vector as a robust and convenient neuroscience tool E Hudry, C Martin, S Gandhi, B György, D I Scheffer, D Mu, S F Merkel, F Mingozzi, Z Fitzpatrick, H Dimant, M Masek, T Ragan, S Tan, A R Brisson, S H Ramirez, B T Hyman and C A Maguire Gene Ther 2016 23: 819; 10.1038/gt.2016.65 Full Text Erratum Top Local gene therapy with indoleamine 2,3-dioxygenase protects against development of transplant vasculopathy in chronic kidney transplant dysfunction D Vavrincova-Yaghi, L E Deelman, H van Goor, M A Seelen, P Vavrinec, I P Kema, P Gomolcak, A Benigni, R H Henning and M Sandovici Gene Ther 2016 23: 820; 10.1038/gt.2016.68 Full Text Advertisement Have you tried listening to the Genepod, the podcast from Genetics in Medicine? Hear direct from the experts, wherever you are and on whatever device. Past topics have included: Investigating the lower risk of solid tumors in Down Syndrome New and Old Quandaries in Newborn Screening Time and effort to practice medical genetics: an expanding challenge Listen to the Genepod and expand your genetics knowledge for free Natureevents is a fully searchable, multi-disciplinary database designed to maximise exposure for events organisers. The contents of the Natureevents Directory are now live. The digital version is available here. Find the latest scientific conferences, courses, meetings and symposia on natureevents.com. For event advertising opportunities across the Nature Publishing Group portfolio please contact natureevents@nature.com More Nature Events Please note that you need to be a subscriber or site-licence holder to enjoy full-text access to Gene Therapy. In order to do so, please purchase a subscription. You have been sent this Table of Contents Alert because you have opted in to receive it. You can change or discontinue your e-mail alerts at any time, by modifying your preferences on your nature.com account at: www.nature.com/nams/svc/myaccount (You will need to log in to be recognised as a nature.com registrant). For further technical assistance, please contact our registration department. For print subscription enquiries, please contact our subscription department. For other enquiries, please contact our customer feedback department. Nature Publishing Group |One New York Plaza, Suite 4500 | New York | NY 10004-1562 | USA Nature Publishing Group's worldwide offices: London - Paris - Munich - New Delhi - Tokyo - Melbourne San Diego - San Francisco - Washington - New York - Boston Macmillan Publishers Limited is a company incorporated in England and Wales under company number 785998 and whose registered office is located at The Campus, 4 Crinan Street, London, N1 9XW. © 2016 Nature Publishing Group, a division of Macmillan Publishers Limited. All Rights Reserved.